A Phase Ib/II Study of Anti-PD-1 Antibody Pembrolizumab and Imprime PGG for Patients with Metastatic Non-small Cell Lung Cancer After Progression on First-Line Chemotherapy

Learn more:

• https://clinicaltrials.gov/study/NCT03003468
• See Study Locations on Big Ten CRC Website